These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
287 related items for PubMed ID: 25356050
1. MicroRNA signatures in chemotherapy resistant esophageal cancer cell lines. Hummel R, Sie C, Watson DI, Wang T, Ansar A, Michael MZ, Van der Hoek M, Haier J, Hussey DJ. World J Gastroenterol; 2014 Oct 28; 20(40):14904-12. PubMed ID: 25356050 [Abstract] [Full Text] [Related]
2. Complex Epigenetic Regulation of Chemotherapy Resistance and Biohlogy in Esophageal Squamous Cell Carcinoma via MicroRNAs. Lindner K, Eichelmann AK, Matuszcak C, Hussey DJ, Haier J, Hummel R. Int J Mol Sci; 2018 Feb 07; 19(2):. PubMed ID: 29414899 [Abstract] [Full Text] [Related]
3. Proton pump inhibitors (PPIs) impact on tumour cell survival, metastatic potential and chemotherapy resistance, and affect expression of resistance-relevant miRNAs in esophageal cancer. Lindner K, Borchardt C, Schöpp M, Bürgers A, Stock C, Hussey DJ, Haier J, Hummel R. J Exp Clin Cancer Res; 2014 Sep 01; 33(1):73. PubMed ID: 25175076 [Abstract] [Full Text] [Related]
4. microRNAs: Key regulators of chemotherapy response and metastatic potential via complex control of target pathways in esophageal adenocarcinoma. Matuszcak C, Lindner K, Eichelmann AK, Hussey DJ, Haier J, Hummel R. Surg Oncol; 2018 Sep 01; 27(3):392-401. PubMed ID: 30217293 [Abstract] [Full Text] [Related]
5. MicroRNA-153-3p regulates cell proliferation and cisplatin resistance via Nrf-2 in esophageal squamous cell carcinoma. Zuo J, Zhao M, Fan Z, Liu B, Wang Y, Li Y, Lv P, Xing L, Zhang X, Shen H. Thorac Cancer; 2020 Mar 01; 11(3):738-747. PubMed ID: 32012470 [Abstract] [Full Text] [Related]
6. Chemotherapy-induced modification of microRNA expression in esophageal cancer. Hummel R, Wang T, Watson DI, Michael MZ, Van der Hoek M, Haier J, Hussey DJ. Oncol Rep; 2011 Oct 01; 26(4):1011-7. PubMed ID: 21743970 [Abstract] [Full Text] [Related]
7. Involvement of microRNA-141-3p in 5-fluorouracil and oxaliplatin chemo-resistance in esophageal cancer cells via regulation of PTEN. Jin YY, Chen QJ, Xu K, Ren HT, Bao X, Ma YN, Wei Y, Ma HB. Mol Cell Biochem; 2016 Nov 01; 422(1-2):161-170. PubMed ID: 27644195 [Abstract] [Full Text] [Related]
8. Mir-148a improves response to chemotherapy in sensitive and resistant oesophageal adenocarcinoma and squamous cell carcinoma cells. Hummel R, Watson DI, Smith C, Kist J, Michael MZ, Haier J, Hussey DJ. J Gastrointest Surg; 2011 Mar 01; 15(3):429-38. PubMed ID: 21246413 [Abstract] [Full Text] [Related]
9. MicroRNA-141 confers resistance to cisplatin-induced apoptosis by targeting YAP1 in human esophageal squamous cell carcinoma. Imanaka Y, Tsuchiya S, Sato F, Shimada Y, Shimizu K, Tsujimoto G. J Hum Genet; 2011 Apr 01; 56(4):270-6. PubMed ID: 21289630 [Abstract] [Full Text] [Related]
10. A novel serum microRNA signature to screen esophageal squamous cell carcinoma. Huang Z, Zhang L, Zhu D, Shan X, Zhou X, Qi LW, Wu L, Zhu J, Cheng W, Zhang H, Chen Y, Zhu W, Wang T, Liu P. Cancer Med; 2017 Jan 01; 6(1):109-119. PubMed ID: 28035762 [Abstract] [Full Text] [Related]
11. miR-145, miR-133a and miR-133b: Tumor-suppressive miRNAs target FSCN1 in esophageal squamous cell carcinoma. Kano M, Seki N, Kikkawa N, Fujimura L, Hoshino I, Akutsu Y, Chiyomaru T, Enokida H, Nakagawa M, Matsubara H. Int J Cancer; 2010 Dec 15; 127(12):2804-14. PubMed ID: 21351259 [Abstract] [Full Text] [Related]
12. MiR-498 in esophageal squamous cell carcinoma: clinicopathological impacts and functional interactions. Islam F, Gopalan V, Law S, Tang JC, Chan KW, Lam AK. Hum Pathol; 2017 Apr 15; 62():141-151. PubMed ID: 28188753 [Abstract] [Full Text] [Related]
13. MiR-141-3p is upregulated in esophageal squamous cell carcinoma and targets pleckstrin homology domain leucine-rich repeat protein phosphatase-2, a negative regulator of the PI3K/AKT pathway. Ishibashi O, Akagi I, Ogawa Y, Inui T. Biochem Biophys Res Commun; 2018 Jun 22; 501(2):507-513. PubMed ID: 29738771 [Abstract] [Full Text] [Related]
14. miR-145 Regulates the sensitivity of esophageal squamous cell carcinoma cells to 5-FU via targeting REV3L. Chen Q, Hou J, Wu Z, Zhao J, Ma D. Pathol Res Pract; 2019 Jul 22; 215(7):152427. PubMed ID: 31072625 [Abstract] [Full Text] [Related]
15. Expression of microRNAs in squamous cell carcinoma of human head and neck and the esophagus: miR-205 and miR-21 are specific markers for HNSCC and ESCC. Kimura S, Naganuma S, Susuki D, Hirono Y, Yamaguchi A, Fujieda S, Sano K, Itoh H. Oncol Rep; 2010 Jun 22; 23(6):1625-33. PubMed ID: 20428818 [Abstract] [Full Text] [Related]
16. MicroRNA-30d inhibits the migration and invasion of human esophageal squamous cell carcinoma cells via the post‑transcriptional regulation of enhancer of zeste homolog 2. Xie R, Wu SN, Gao CC, Yang XZ, Wang HG, Zhang JL, Yan W, Ma TH. Oncol Rep; 2017 Mar 22; 37(3):1682-1690. PubMed ID: 28184915 [Abstract] [Full Text] [Related]
17. Gastric adenocarcinoma has a unique microRNA signature not present in esophageal adenocarcinoma. Chen Z, Saad R, Jia P, Peng D, Zhu S, Washington MK, Zhao Z, Xu Z, El-Rifai W. Cancer; 2013 Jun 01; 119(11):1985-93. PubMed ID: 23456798 [Abstract] [Full Text] [Related]
18. MicroRNA profile in neosquamous esophageal mucosa following ablation of Barrett's esophagus. Sreedharan L, Mayne GC, Watson DI, Bright T, Lord RV, Ansar A, Wang T, Kist J, Astill DS, Hussey DJ. World J Gastroenterol; 2017 Aug 14; 23(30):5508-5518. PubMed ID: 28852310 [Abstract] [Full Text] [Related]
19. MicroRNA-624-mediated ARRDC3/YAP/HIF1α axis enhances esophageal squamous cell carcinoma cell resistance to cisplatin and paclitaxel. Yan J, Shi L, Lin S, Li Y. Bioengineered; 2021 Dec 14; 12(1):5334-5347. PubMed ID: 34415232 [Abstract] [Full Text] [Related]
20. [Correlations between miRNAs and TGF-β1 in tumor microenvironment of esophageal squamous cell cancer]. Zhu L, Jin L, Jiang R, Wang Q, Jiang J, Mao C, Chen D. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2013 May 14; 29(5):524-8. PubMed ID: 23643275 [Abstract] [Full Text] [Related] Page: [Next] [New Search]